Abstract

3 Oral - USP1 inhibitors show robust combination activity and a distinct resistance profile from PARP inhibitors

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call